Antimicrobial Use Guidelines (AMUG) version 21 - UW Health
Antimicrobial Use Guidelines (AMUG) version 21 - UW Health
Antimicrobial Use Guidelines (AMUG) version 21 - UW Health
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
E. References1. Ramirez JA. Antibiotic streamlining: development and justification of an antibioticstreamlining program. Pharmacy Practice Management Quarterly 1996;16:19-34.2. Cunha BA. Community-acquired pneumonia-cost-effective antimicrobial therapy. PostgradMed 1996;99:62-4.3. Okapara AU, Maswoswe JJ, Stewart K. Criteria-based antimicrobial i.v. to oral con<strong>version</strong>program. Formulary 1995;30:343-8.4. Jewesson P. Cost-effectiveness and value of an IV switch. Pharmacoeconomics 1994;5(Suppl 2):20-26.5. Parker SE, Davey PG. Pharmacoecomics of intravenous drug administration.Pharmacoeconomics 1992;1:103-15.6. Przybylski KG, Rybak MJ, Martin PR, et al. A pharmacist-initiated program of intravenous tooral antibiotic con<strong>version</strong>. Pharmacotherapy 1997;17:271-6.7. Zamin MT, Pitre MM, Conly JM. Development of an intravenous-to-oral con<strong>version</strong> programfor antimicrobial therapy at a Canadian tertiary care health facility. Annals ofPharmacotherapy 1997;31:564-70.8. Goldwater SH, Neal-Janifer A, Milkovich G, et al. Smoothing the path for I.v.-to-oralcon<strong>version</strong>. AJHP 1997;54:200.9. Wetzstein GA. Intravenous to oral (iv:po) anti-infective con<strong>version</strong> therapy. Cancer Control.2000 Mar-Apr;7(2):170-6.10. Fischer MA, Solomon DH, Teich JM, Avorn J. Con<strong>version</strong> from intravenous to oralmedications: assessment of a computerized intervention for hospitalized patients. Arch InternMed. 2003 Nov 24;163(<strong>21</strong>):2585-9.11. Ho BP, Lau TT, Balen RM, Naumann TL, Jewesson PJ. The impact of a pharmacistmanageddosage form con<strong>version</strong> service on ciprofloxacin usage at a major Canadianteaching hospital: a pre- and post-intervention study. BMC <strong>Health</strong> Serv Res. 2005 Jun29;5:48.12. Teich JM, Petronzio AM, Gerner JR, Seger DL, Shek C, Fanikos J. An information system topromote intravenous-to-oral medication con<strong>version</strong>. Proc AMIA Symp. 1999;:415-9.13. Pisegna JR: Switching between intravenous and oral pantoprazole. J Clin Gastroenterol2001; 32(1):27-32.14. Fish LH, Schwartz HL, Cavanaugh J, et al: Replacement dose, metabolism, andbioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine inpituitary feedback in humans. N Engl J Med 1987; 316(13):764-770
Change language